Plerixafor in combination with originator or biosimilar XM02-G-CSF as first-line peripheral blood stem cell mobilisation strategy in patients with lymphomas and multiple myeloma candidate to ASCT: a single-centre experience
BONE MARROW TRANSPLANTATION(2012)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要